Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 1
2012 3
2013 1
2014 2
2017 7
2018 4
2019 7
2020 9
2021 6
2022 8
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Triple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes.
Barry PJ, Mall MA, Álvarez A, Colombo C, de Winter-de Groot KM, Fajac I, McBennett KA, McKone EF, Ramsey BW, Sutharsan S, Taylor-Cousar JL, Tullis E, Ahluwalia N, Jun LS, Moskowitz SM, Prieto-Centurion V, Tian S, Waltz D, Xuan F, Zhang Y, Rowe SM, Polineni D; VX18-445-104 Study Group. Barry PJ, et al. N Engl J Med. 2021 Aug 26;385(9):815-825. doi: 10.1056/NEJMoa2100665. N Engl J Med. 2021. PMID: 34437784 Free PMC article. Clinical Trial.
Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis.
Leroy C, Spelier S, Essonghe NC, Poix V, Kong R, Gizzi P, Bourban C, Amand S, Bailly C, Guilbert R, Hannebique D, Persoons P, Arhant G, Prévotat A, Reix P, Hubert D, Gérardin M, Chamaillard M, Prevarskaya N, Rebuffat S, Shapovalov G, Beekman J, Lejeune F. Leroy C, et al. Among authors: prevotat a. Mol Ther. 2023 Apr 5;31(4):970-985. doi: 10.1016/j.ymthe.2023.01.014. Epub 2023 Jan 14. Mol Ther. 2023. PMID: 36641622 Free PMC article.
[Chronic respiratory diseases: Being a psychologist in a hospital].
Vanneste J, Flament S, Bourjot A, Leclercq E, Prevotat A. Vanneste J, et al. Among authors: prevotat a. Rev Mal Respir. 2018 May;35(5):489-493. doi: 10.1016/j.rmr.2018.05.011. Rev Mal Respir. 2018. PMID: 29891052 French. No abstract available.
Fertility of women with cystic fibrosis: a French survey.
Tournier A, Murris M, Prevotat A, Fanton A, Bettiol C, Parinaud J. Tournier A, et al. Among authors: prevotat a. Reprod Biomed Online. 2019 Sep;39(3):492-495. doi: 10.1016/j.rbmo.2019.04.128. Epub 2019 May 7. Reprod Biomed Online. 2019. PMID: 31256948
Effects of a Partially Supervised Conditioning Program in Cystic Fibrosis: An International Multicenter, Randomized Controlled Trial (ACTIVATE-CF).
Hebestreit H, Kriemler S, Schindler C, Stein L, Karila C, Urquhart DS, Orenstein DM, Lands LC, Schaeff J, Eber E, Radtke T; ACTIVATE-CF Study Working Group. Hebestreit H, et al. Am J Respir Crit Care Med. 2022 Feb 1;205(3):330-339. doi: 10.1164/rccm.202106-1419OC. Am J Respir Crit Care Med. 2022. PMID: 34735776 Free PMC article. Clinical Trial.
Pulmonary hemorrhage in a neonate born to a woman with cystic fibrosis treated with targeted cystic fibrosis transmembrane conductance regulator modulator elexacaftor-tezacaftor-ivacaftor during pregnancy.
Nuytten A, Prevotat A, Le Rouzic O, Dekemp J, Gilliot S, Gautier S, Le Duc K, Garabedian C. Nuytten A, et al. Among authors: prevotat a. Therapie. 2022 Nov-Dec;77(6):743-745. doi: 10.1016/j.therap.2022.01.020. Epub 2022 Mar 7. Therapie. 2022. PMID: 35606190 No abstract available.
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.
Cosgriff R, Ahern S, Bell SC, Brownlee K, Burgel PR, Byrnes C, Corvol H, Cheng SY, Elbert A, Faro A, Goss CH, Gulmans V, Marshall BC, McKone E, Middleton PG, Ruseckaite R, Stephenson AL, Carr SB; Global Registry Harmonization Group. Cosgriff R, et al. J Cyst Fibros. 2020 May;19(3):355-358. doi: 10.1016/j.jcf.2020.04.012. Epub 2020 Apr 25. J Cyst Fibros. 2020. PMID: 32376098 Free PMC article.
Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study.
Meijer L, Hery-Arnaud G, Leven C, Nowak E, Hillion S, Renaudineau Y, Durieu I, Chiron R, Prevotat A, Fajac I, Hubert D, Murris-Espin M, Huge S, Danner-Boucher I, Ravoninjatovo B, Leroy S, Macey J, Urban T, Rault G, Mottier D, Berre RL. Meijer L, et al. Among authors: prevotat a. J Cyst Fibros. 2022 May;21(3):529-536. doi: 10.1016/j.jcf.2021.10.013. Epub 2021 Dec 24. J Cyst Fibros. 2022. PMID: 34961705 Free article. Clinical Trial.
Spatial and Temporal Virus Load Dynamics of SARS-CoV-2: A Single-Center Cohort Study.
Alidjinou EK, Poissy J, Ouafi M, Caplan M, Benhalima I, Goutay J, Tinez C, Faure K, Chopin MC, Yelnik C, Lambert M, Hober D, Preau S; The Lille COVID Research Network (LICORNE); Nseir S, Engelmann I. Alidjinou EK, et al. Diagnostics (Basel). 2021 Mar 3;11(3):427. doi: 10.3390/diagnostics11030427. Diagnostics (Basel). 2021. PMID: 33802451 Free PMC article.
49 results